Preemptive iron supplementation prevents myocardial iron deficiency and attenuates adverse remodelling after myocardial infarction

• Published in: Cardiovascular research
• Main Authors: Chung, Bomee, Wang, Yong, Thiel, Marleen, Rostami, Fatemeh, Rogoll, Anika, Hirsch, Valentin G, Malik, Zulaikha, Bührke, Anne, Bär, Christian, Klintschar, Michael, Schmitto, Jan D, Vogt, Carla, Werlein, Christopher, Jonigk, Danny, Bauersachs, Johann, Wollert, Kai C, Kempf, Tibor
• Format: Journal Article
• Language: English
• Published: England 14.06.2023
• ISSN: 1755-3245

Heart failure (HF) after myocardial infarction (MI) is a major cause of morbidity and mortality. We sought to investigate the functional importance of cardiac iron status after MI and the potential of preemptive iron supplementation in preventing cardiac iron deficiency (ID) and attenuating left ventricular (LV) remodelling. MI was induced in C57BL/6J male mice by left anterior descending coronary artery ligation. Cardiac iron status in the non-infarcted LV myocardium was dynamically regulated after MI: non-haem iron and ferritin increased at 4 weeks but decreased at 24 weeks after MI. Cardiac ID at 24 weeks was associated with reduced expression of iron-dependent electron transport chain (ETC) complex I compared with sham-operated mice. Hepcidin expression in the non-infarcted LV myocardium was elevated at 4 weeks and suppressed at 24 weeks. Hepcidin suppression at 24 weeks was accompanied by more abundant expression of membrane-localised ferroportin, the iron exporter, in the non-infarcted LV myocardium. Notably, similarly dysregulated iron homeostasis was observed in LV myocardium from failing human hearts, which displayed lower iron content, reduced hepcidin expression, and increased membrane-bound ferroportin. Injecting ferric carboxymaltose (15 µg/g body weight) intravenously at 12, 16, and 20 weeks after MI preserved cardiac iron content and attenuated LV remodelling and dysfunction at 24 weeks compared with saline-injected mice. We demonstrate, for the first time, that dynamic changes in cardiac iron status after MI are associated with local hepcidin suppression, leading to cardiac ID long-term after MI. Preemptive iron supplementation maintained cardiac iron content and attenuated adverse remodelling after MI. Our results identify the spontaneous development of cardiac ID as a novel disease mechanism and therapeutic target in postinfarction LV remodelling and HF.